How to Research and Present on Health Policy Interest Groups
A group-by-group guide for health policy and public administration students — covering how to extract lobbying data from OpenSecrets, how to analyze position statements and congressional testimony, how to identify key policy obstacles, and how to structure a presentation that earns full analytical marks.
Interest group presentations are one of the most research-intensive assignments in health policy courses because they require you to synthesize three distinct data streams: financial lobbying records, primary-source organizational materials, and external media and policy reporting. Most presentations fail not because students chose the wrong group, but because they describe what the group wants without analyzing how it pursues those goals, what stands in its way, and what the spending data reveals about its strategic priorities. This guide walks you through every step of the research and presentation process for each of the five groups assigned.
This is not an organization profile. You are not describing what AARP or PhRMA does in general terms. You are analyzing how a specific interest group uses specific mechanisms — lobbying, PAC contributions, grassroots mobilization, coalition building, testimony — to move specific policy outcomes in a specific direction, and what structural or political obstacles prevent full success. Every slide must carry analytical weight. “AARP advocates for seniors” is description. “AARP deployed grassroots member mobilization in 38 states to defeat Medicare Advantage cut proposals in the 2021 reconciliation package, while simultaneously contributing $X in PAC money to Finance Committee members” is analysis. The distinction determines your grade.
What This Guide Covers
What the Assignment Is Actually Testing
The interest group presentation tests three competencies simultaneously. First, empirical research skill — can you locate and correctly interpret lobbying disclosure data, campaign finance records, and legislative testimony? Second, political science conceptual knowledge — do you understand how interest groups actually operate within the policy process, including which mechanisms are most effective in which contexts? Third, analytical synthesis — can you connect the group’s stated agenda, its financial activity, its coalition strategy, and the obstacles it faces into a coherent argument about its policy influence?
The two questions frame a complete analytical arc: Question 1 asks about the group’s mechanisms, obstacles, and spending — the operational reality of its lobbying. Question 2 asks you to go to the primary sources — the group’s own website, its congressional testimony, and media coverage — and verify, enrich, or complicate what the spending data shows. Together, they require you to triangulate across at least three independent source types. A presentation that draws only from one source type — only OpenSecrets, or only the organization’s website — cannot satisfy both questions and will be graded down for incomplete research.
How to Use OpenSecrets Correctly
OpenSecrets — operated by the Center for Responsive Politics at opensecrets.org — is the primary verified source for federal lobbying expenditure and campaign contribution data. It aggregates disclosures filed under the Lobbying Disclosure Act with the Senate Office of Public Records and campaign finance filings with the Federal Election Commission. Understanding what the data does and does not show is essential to interpreting it correctly in your presentation.
The Center for Responsive Politics publishes its data methodology at opensecrets.org/about/methodology. Before using any figures in your presentation, read this page — it explains how lobbying totals are calculated, what is and is not included in PAC figures, and how industry-level aggregations are constructed. Citing figures without understanding the methodology behind them is a common error that professors in policy courses specifically look for. Knowing that lobbying totals reflect self-reported expenditures subject to LDA thresholds — and that grassroots lobbying is excluded from these disclosures — is analytically important context for your presentation.
The Six Core Lobbying Mechanisms to Analyze
Your presentation must identify which specific mechanisms your chosen group uses and analyze how effectively it deploys them. Not all groups use all mechanisms — part of the analytical work is explaining which combination a particular group relies on and why that combination reflects its membership base, resources, and policy context.
Direct Lobbying
Registered lobbyists paid to contact members of Congress, congressional staff, and executive agency officials directly. Disclosed on LD-2 filings. Look at OpenSecrets to identify how many lobbyists the organization employs, what percentage are revolving-door hires with prior government service, and which federal agencies and congressional committees they target.
PAC and Campaign Contributions
Financial contributions to candidates and party committees through a PAC or Super PAC vehicle. Look at OpenSecrets PAC data for total cycle contributions, split between Republican and Democratic recipients, and concentration on committee members with jurisdiction over the group’s priority legislation. Bipartisan giving is a deliberate access strategy — identify whether your group practices it.
Grassroots Mobilization
Organizing members, constituents, or the public to contact their elected officials directly. AARP is the dominant practitioner of this mechanism given its 38 million members. Grassroots lobbying is not disclosed under the LDA — it does not appear in OpenSecrets figures — which means the true scope of influence activity for membership-based groups is systematically underrepresented in spending data alone.
Coalition Building
Forming or joining alliances with other organizations to present a broader front on shared legislative priorities. Identify which coalitions your group participates in or leads — this often appears on their website under “partners” or “coalition” pages. Coalition membership expands political reach beyond the group’s own member base and distributes the reputational cost of aggressive advocacy.
Testimony and Public Comment
Providing formal testimony before congressional committees and submitting public comments during federal rulemaking processes. This is a primary source mechanism — congressional testimony is publicly available on congress.gov and in committee records. Rulemaking comments are available at regulations.gov. Both allow you to identify exactly which policy positions the group formally advanced and when.
Media and Public Relations
Issue advertising, op-eds, press releases, social media campaigns, and think-tank-funded research to shape the public and legislative narrative. Search for your group’s press releases and recent media coverage using Google News and LexisNexis. Identify whether the group’s public communications align with its legislative priorities — and look for cases where they diverge, which often signals a gap between public positioning and private lobbying goals.
AARP — Research and Presentation Framework
Who AARP Is and Why It Is a Distinct Type of Interest Group
AARP is a membership-based nonprofit representing adults 50 and over with approximately 38 million members. It is the largest membership-based interest group in the United States and derives its political power primarily from member mobilization rather than financial spending — which makes it analytically distinct from trade associations like PhRMA or AHIP. Your presentation must reflect this distinction: AARP’s lobbying expenditure figures on OpenSecrets are significant but do not capture the full scope of its political influence because grassroots contact campaigns — not disclosed under the LDA — are its most powerful tool.
How to Research AARP’s Mechanisms and Agenda
Start at opensecrets.org/orgs/aarp — examine total lobbying expenditures over the past five years, the specific bills reported in LD-2 filings, and PAC contribution recipients. Then go to aarp.org/politics-society/advocacy for their formal policy positions and active campaigns. AARP’s primary legislative priorities cluster around three areas: Medicare benefit protection and expansion (particularly drug pricing policy), Social Security solvency, and long-term care financing. For each priority, identify the specific bill or regulatory action at stake, the legislative vehicle AARP is targeting, and the opposition it faces. AARP’s most significant current obstacle is the structural coalition between fiscal conservatives and deficit hawks who oppose benefit expansion on cost grounds — identify the specific legislators and caucuses that form this opposition and how AARP has attempted to respond.
AARP: Mechanisms to Highlight
- Member mobilization: AARP’s “Take a Stand” and similar campaigns coordinate constituent contact with specific legislators — search AARP’s newsroom for recent mobilization campaigns and identify which bills they targeted
- State-level lobbying: AARP maintains advocacy offices in all 50 states — their state-level activity on Medicaid, long-term care, and prescription drug access is significant and documented in state lobbying disclosures
- Research and framing: AARP Public Policy Institute produces widely cited research used to frame legislative debates — identify recent PPI reports and trace their use in congressional committee hearings
- Electoral presence: AARP formally declines to endorse candidates but operates AARP Action, a c(4) social welfare organization that runs issue ads targeting vulnerable legislators
AARP: Key Obstacles to Present
- Budget constraint politics: Every AARP priority involves spending — Medicare expansion, drug pricing, long-term care — and faces unified opposition from deficit hawks regardless of party
- Generational framing: Opponents regularly frame AARP priorities as intergenerational transfers that disadvantage younger workers; AARP has not successfully neutralized this argument in the public narrative
- Internal member diversity: AARP’s 38 million members include both high-income retirees and low-income seniors with very different policy needs — maintaining a unified advocacy position across this range constrains what positions AARP can take
- Pharmaceutical industry opposition: On drug pricing — AARP’s highest-profile current campaign — PhRMA is a direct and well-funded opponent with overlapping access to the same legislators
AHIP — Research and Presentation Framework
Who AHIP Is and What Makes It a Trade Association Lobbyist
America’s Health Insurance Plans (AHIP) is the national trade association representing the health insurance industry — commercial insurers, managed care organizations, and pharmacy benefit managers. Unlike AARP, AHIP does not have a membership base of individual citizens; it represents corporate members whose combined market power makes it one of the most financially significant trade association lobbyists in the health sector. AHIP’s lobbying strategy combines direct lobbying with a significant public communications operation designed to shape the public narrative about insurance industry practices and reform proposals.
How to Research AHIP’s Mechanisms and Agenda
Search opensecrets.org for “America’s Health Insurance Plans” to find both direct lobbying expenditures and PAC contribution records. AHIP’s lobbying filings are particularly detailed — the issue areas and specific bills listed reveal whether AHIP is primarily playing defense against government pricing controls and public option proposals, or offense in support of market-based frameworks. AHIP’s official website at ahip.org maintains a policy section with formal position papers and a newsroom with press releases and media statements. For testimony, search congress.gov for “America’s Health Insurance Plans” in the witness list for Energy and Commerce and Finance Committee hearings. AHIP representatives testify regularly on Medicare Advantage, ACA marketplace stability, and drug pricing transparency — each testimony document tells you exactly what legislative position AHIP was formally advocating at that moment.
PhRMA — Research and Presentation Framework
Why PhRMA Is the Highest-Profile Lobbying Target in Health Policy
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the brand-name pharmaceutical industry — the largest-spending lobbying sector in the U.S. economy for most of the past two decades. PhRMA’s lobbying expenditures are consistently among the highest of any single trade association in Washington, and its agenda — protecting patent exclusivity periods, opposing government drug price negotiation, and limiting drug importation — sits at the center of the most contested health policy battles of the current legislative era. PhRMA is simultaneously the most financially powerful health industry lobbyist and the industry with the lowest public trust scores, which creates a distinctive strategic tension your presentation should analyze.
How to Research PhRMA’s Mechanisms and Spending
Search OpenSecrets for “Pharmaceutical Research and Manufacturers of America” — you will find one of the largest lobbying expenditure profiles in the database. Examine year-by-year spending totals and identify the years where spending spiked — these correspond to major legislative threats (ACA passage, Medicare Part D renegotiation debates, Inflation Reduction Act drug pricing provisions). The spike years are analytically significant: they show the group moving from maintenance lobbying to crisis defense spending. For the specific bills lobbied, click through to individual LD-2 filing records on opensecrets.org — you will find that PhRMA files among the most detailed disclosures of any organization, listing dozens of specific bill numbers per quarter. PhRMA’s website at phrma.org maintains an “Issues” section with formal position papers. Cross-reference every position paper with recent congressional testimony at congress.gov to identify where the organization has formally advocated before committees with jurisdiction.
PhRMA: Mechanisms to Highlight
- Coalitions with patient advocacy groups: PhRMA funds or co-organizes coalitions with patient advocacy organizations who frame drug pricing opposition in terms of access and innovation rather than industry profit — research specific coalition groups and their documented PhRMA funding connections
- Think-tank funding: PhRMA funds research at policy institutes that produce publications supporting industry positions on innovation incentives — identify specific think tanks and recent publications by name
- Issue advertising: PhRMA runs sustained issue ad campaigns opposing government price setting — track recent campaigns through news coverage and AHIP’s and PhRMA’s own communications archives
- Direct lobbying concentration: PhRMA focuses heavily on Senate Finance and House Energy & Commerce; identify which current committee members receive PhRMA PAC contributions and where they stand on drug pricing bills
PhRMA: Key Obstacles to Present
- Public opinion: Drug pricing is among the most salient public policy issues in health surveys; bipartisan polling shows overwhelming support for government price negotiation, which reduces legislators’ political cover for opposing it
- Inflation Reduction Act provisions: The 2022 IRA enacted limited Medicare drug price negotiation for the first time — a significant legislative defeat for PhRMA that your presentation should address explicitly, including PhRMA’s legal challenges to its implementation
- Internal industry fragmentation: Generic drug manufacturers and biosimilar producers do not share PhRMA’s patent protection interests — the pharmaceutical industry is not monolithic, and this internal division limits PhRMA’s coalition breadth
- Bipartisan opposition: Drug pricing is one of the few health policy areas where conservative populists and progressive advocates converge — PhRMA faces opposition from both sides, limiting its ability to play partisan defense
Emergency Nurses Association — Research and Presentation Framework
ENA as a Professional Association Lobbyist — A Different Model
The Emergency Nurses Association (ENA) represents approximately 50,000 emergency nursing professionals and operates as a professional association rather than a trade association or membership advocacy organization. This distinction matters analytically: ENA’s lobbying power derives primarily from professional credibility and expert testimony rather than financial spending or mass mobilization. ENA’s lobbying footprint on OpenSecrets will be significantly smaller than AARP or PhRMA — which is itself analytically important. Smaller spending does not mean less policy influence; it means a different mechanism mix weighted toward expert testimony, professional coalition building, and regulatory comment rather than financial access strategies.
How to Research ENA’s Mechanisms and Agenda
Search OpenSecrets for “Emergency Nurses Association” — expect a much smaller lobbying expenditure profile than the large trade associations. Examine which issue areas and bills appear in their LDA filings: ENA’s core legislative priorities include emergency department staffing ratios, workplace violence protections for healthcare workers, and emergency care access funding. ENA’s website at ena.org maintains a government affairs section with current legislative priorities and formal position statements. The most valuable primary source for ENA is congressional testimony — search congress.gov for ENA representatives testifying before health subcommittees on emergency care legislation. ENA’s testimony reflects the group’s positioning as a scientific and clinical expert rather than a financial stakeholder, which is a distinct strategic framing your presentation should identify.
ENA Priority: Workplace Violence
ENA has consistently advanced federal legislation requiring workplace violence prevention programs in healthcare settings. Research the specific bills ENA has supported — including the Workplace Violence Prevention for Health Care and Social Service Workers Act — identify which congressional sessions it was introduced, and trace ENA’s testimony and coalition partnerships on this issue. This is ENA’s longest-running and most visible legislative campaign.
ENA Priority: Staffing and Access
ENA advocates for emergency department staffing standards and policies that protect emergency care access, including opposition to certain cost-containment policies that affect ED triage and treatment protocols. Look for ENA’s formal position statements on CMS rulemaking — these are submitted as public comments to regulations.gov and are a primary source that most students miss because they focus only on congressional testimony.
ENA’s Obstacle: Institutional Asymmetry
ENA’s primary obstacle is resource asymmetry — it competes for legislative attention against hospital associations, insurance industry groups, and physician associations that have far larger lobbying budgets. ENA’s strategy for managing this asymmetry is coalition building with other nursing and allied health professional organizations. Identify ENA’s formal coalition partnerships — particularly with the American Nurses Association and specialty nursing associations — and explain how coalition participation compensates for ENA’s limited independent spending capacity.
Coalition for Health Services Research — Research and Presentation Framework
CHSR as a Research Advocacy Coalition — The Evidence-Based Lobbying Model
The Coalition for Health Services Research is an umbrella coalition that advocates for federal funding and policy support for health services research — particularly the Agency for Healthcare Research and Quality (AHRQ). CHSR’s membership includes academic medical centers, research universities, health policy institutes, and professional associations whose research missions depend on federal AHRQ and comparative effectiveness research funding. This makes CHSR analytically distinct from all other groups on the list: its policy agenda is not about direct market regulation or member benefits — it is about preserving and expanding the federal research infrastructure that produces the evidence base that other health policy decisions depend on.
How to Research CHSR’s Mechanisms, Agenda, and Obstacles
CHSR may have a smaller direct lobbying footprint than the large trade associations — search OpenSecrets and cross-reference with the Senate LDA database directly at lda.senate.gov to locate any lobbying disclosure filings. CHSR’s primary website and advocacy materials may be more difficult to locate than the large associations — search for the organization’s formal name and check for an organizational website and any congressional testimony records. For CHSR specifically, look at the record of AHRQ appropriations debates in Congress — AHRQ has been subject to repeated attempts to eliminate or defund it, and CHSR’s advocacy work is most visible in the record of those budget fights. Appropriations committee hearing records, available on congress.gov, will show CHSR-affiliated witnesses defending AHRQ’s budget. Your presentation should focus on this specific legislative context: defending existing research infrastructure against defunding is a different kind of advocacy challenge than advancing new legislation.
CHSR is less prominent in OpenSecrets than the other four groups. If your OpenSecrets search returns limited data, supplement with: (1) direct searches on the Senate LDA database at lda.senate.gov for lobbying disclosures; (2) AHRQ’s own budget justification documents, available at ahrq.gov, which describe the research advocacy context; (3) legislative history of AHRQ appropriations in recent congressional sessions, searchable on congress.gov; and (4) news and policy publication coverage of AHRQ budget debates, searchable in LexisNexis or ProQuest. The absence of large OpenSecrets figures for CHSR is not a research failure — it is a finding that your presentation should explicitly address: smaller-spending coalitions rely more heavily on expert testimony and member institution credibility than on financial access strategies.
How to Analyze an Interest Group’s Website
Question 2 requires you to go to the interest group’s website directly. The website is a primary source — not a secondary or background source — and must be treated as such in your presentation. What an organization publishes on its own website is a formal statement of how it wants to be perceived and what it wants policymakers to prioritize. Analyzing it analytically, rather than just reading it at face value, is the skill this question tests.
-
Locate the Policy or Advocacy Section
Every major interest group maintains a dedicated policy or government affairs section on its website. Look for headings like “Advocacy,” “Policy,” “Government Affairs,” “Issues,” or “Legislative Priorities.” This section will contain the group’s formal position statements on current policy issues. For each position statement, identify: the specific policy at stake, the group’s stated position, the argument it uses to justify that position, and — critically — what the position does not say, which often reveals what the group is strategically avoiding.
-
Find Published Testimony and Comment Letters
Many groups publish the testimony their representatives submitted to congressional committees and the comment letters they submitted during federal rulemaking. These are the most analytically precise statements of the group’s policy positions — more specific than general position statements because they are addressed to a specific legislative or regulatory question. Treat these as the primary source that most directly answers Question 2. If the group does not publish these on its website, find them independently through congress.gov or regulations.gov and note whether the gap between website framing and formal testimony reveals any strategic inconsistency.
-
Review Press Releases and Newsroom Content
The group’s newsroom reveals which policy moments it chose to respond to publicly — and which it did not. A press release responding to a committee markup or a floor vote tells you what legislative activity the group was monitoring closely enough to issue a rapid public statement. Silence after a significant vote can be as analytically informative as a statement: if PhRMA does not publicly comment on a drug pricing bill that passed committee, ask why — and whether its direct lobbying activity, visible in the LD-2 filings, tells a different story than its public silence.
-
Examine Coalition Memberships and Partner Organizations
The “Partners,” “Coalitions,” or “About” sections of most interest group websites list affiliated organizations, coalitions participated in, and formal endorsement relationships. Map these connections in your presentation — a group that participates in ten healthcare coalitions has a different political footprint than one that operates independently. For PhRMA and AHIP particularly, identify whether they are listed as funders or founding members of patient advocacy coalitions, which is a documented indirect lobbying mechanism that your presentation should explicitly name.
How to Find and Analyze Congressional Testimony
Congressional testimony is the most direct primary source for identifying exactly what policy positions an interest group formally advocated before the body with legislative authority. It is also the source most students fail to find because they do not know the correct databases to search.
Where to Find Testimony: congress.gov
Go to congress.gov and select “Committees” from the navigation. Select the Senate or House committee with jurisdiction over your group’s primary issue — Finance Committee for Medicare and drug pricing, HELP Committee for health workforce and public health, Energy & Commerce for insurance and pharmaceutical policy. Within each committee page, select “Hearings” and search the witness list for your organization’s name or a representative’s name. Each hearing record links to the submitted testimony document, which is the primary source you need. Most committee hearing testimony from the past decade is available in full text.
- Filter by committee with jurisdiction over your group’s issue area
- Search witness lists — testimony documents are linked directly
- Note the hearing title and date — they identify the legislative context
What to Look for in Testimony Documents
A testimony document has a formal structure: it identifies the witness, their organizational affiliation, the hearing date and committee, and then the substantive statement. For your presentation, extract: (1) the specific policy position being advocated — not a summary, but the exact legislative ask; (2) the evidence or arguments used to support the position — data citations, expert authority claims, member impact stories; (3) the framing strategy — is the group framing its position in terms of public interest, economic efficiency, patient outcomes, or innovation protection? The framing choice is itself analytically significant.
- Note the specific bill number or regulatory action referenced
- Identify the evidence base used — whose data does the group rely on?
- Compare testimony framing to OpenSecrets spending priorities for consistency
Identifying and Presenting Key Obstacles
The “key obstacles” component of Question 1 is where most presentations are weakest. Students typically name one generic obstacle — “opposition from Congress” or “partisan disagreement” — without specifying the structural, political, or coalition-based reasons why the group faces resistance. Obstacles must be specific to the group, the issue, and the current legislative context.
| Group | Primary Obstacle Category | Specific Structural Obstacle to Research and Name |
|---|---|---|
| AARP | Fiscal politics / competing interests | Senate Finance Committee procedural constraints on benefit expansion; bipartisan deficit concern coalitions that oppose new entitlement spending regardless of AARP’s member mobilization capacity |
| AHIP | Public credibility / bipartisan skepticism | Declining public trust in insurance industry; progressive-populist coalition supporting public option proposals that directly threaten AHIP member market position; Medicare Advantage overpayment scrutiny from both parties |
| PhRMA | Public opinion / bipartisan opposition | Inflation Reduction Act precedent establishing government price negotiation; IRA legal challenges losing in court; bipartisan polling showing 80%+ support for drug pricing action reduces legislators’ political protection for industry-aligned votes |
| ENA | Resource asymmetry / agenda crowding | Limited financial capacity relative to hospital and insurance industry lobbyists; workplace violence legislation faces opposition from hospital associations that resist mandatory program requirements; staffing ratio bills face cost-based opposition from health system employers |
| CHSR | Political salience / budget competition | AHRQ research funding lacks strong constituent advocates in most congressional districts; annual appropriations process subjects it to discretionary spending caps; anti-regulatory factions use AHRQ comparative effectiveness research as a target for government overreach arguments |
How to Structure the Presentation
The presentation needs to cover two discrete questions with enough depth to demonstrate research competency without exceeding available time. The structure below applies regardless of which group you chose. Adjust the depth of each section based on your time limit.
-
Opening: Group Identity and Policy Position (1–2 slides)
Identify the group by type — membership organization, trade association, professional association, or advocacy coalition. State its primary policy agenda in one or two sentences, using the language of its own formal position statements rather than a paraphrase. Identify the one or two current legislative issues where the group is most actively engaged. This section establishes the analytical context for everything that follows — do not use it for organizational history or general description that could be found on Wikipedia.
-
Lobbying Mechanisms (2–3 slides)
For each mechanism your group uses, name it precisely — direct lobbying, grassroots mobilization, PAC contributions, coalition building, testimony, media strategy — and provide one concrete example from your research. The example must be specific: a named bill, a named hearing, a named coalition, a named legislator, or a specific OpenSecrets figure. Vague claims like “AARP uses grassroots lobbying” without a specific campaign example are not analytical. Your mechanism analysis should also address which mechanisms your group does not use heavily and explain why — the absence of mass membership mobilization for PhRMA, for example, reflects both capacity limits and strategic calculation.
-
Spending Analysis from OpenSecrets (1–2 slides)
Present actual figures from OpenSecrets — total lobbying expenditure for at least two recent years, PAC contribution totals with partisan breakdown, and the top three or four recipient legislators with their committee assignments. If your group’s spending spiked in a specific year, identify the legislative event that caused it — a bill introduction, a committee markup, or a floor vote. Do not just display numbers; analyze what the numbers reveal about strategic priorities. The committee assignments of PAC recipients are more analytically significant than the dollar amounts alone.
-
Website and Primary Source Analysis (2 slides)
Present findings from the group’s website, formal position statements, and congressional testimony. Use direct quotes from position statements or testimony where they are analytically precise — not as decoration, but when the group’s exact language reveals something about its framing strategy that a paraphrase would obscure. Identify any gap between the group’s public-facing communications and its registered lobbying activity on specific bills — this gap, when it exists, is one of the most analytically interesting findings a presentation can surface.
-
Key Obstacles and Strategic Assessment (1–2 slides)
Present two or three specific obstacles — not generic partisan gridlock, but named structural or coalition-based barriers — and assess how effectively the group is managing them. Your assessment should be based on evidence: if AARP’s grassroots mobilization campaign on drug pricing produced a specific legislative outcome, cite it. If PhRMA’s legal challenge to IRA drug pricing provisions failed in court, name the court and the ruling. Assessments without evidence are opinions; assessments supported by documented outcomes are analysis.
-
Conclusion: Analytical Takeaway (1 slide)
State one non-obvious conclusion your research supports — something that would not be apparent from a casual reading of the group’s website or a general description of lobbying. For example: “PhRMA’s most effective current mechanism is not direct lobbying but patient coalition funding, because public credibility constraints limit the direct approach.” Or: “ENA’s resource asymmetry is partially offset by the credibility of its expert testimony in hearings, where clinical specificity carries analytical weight that financial access cannot replicate.” This conclusion signals analytical thinking to your professor.
Where Most Presentations Lose Points
Citing OpenSecrets Numbers Without Context
“PhRMA spent $28 million on lobbying last year.” This is a fact, not an analysis. Presenting a number without explaining what it was spent on, which bills it targeted, whether it represents an increase or decrease from prior years, and which legislators received associated PAC contributions provides no analytical value. A professor grading this presentation cannot tell whether you understand what the number means.
Instead
Present the number with its context: “PhRMA’s lobbying expenditure spiked by X% in [year] corresponding to the introduction of the [specific bill]. LD-2 filings for that period list [bill numbers] as targets, and PAC contributions in the same cycle were concentrated on [named senators/representatives] sitting on the Finance Committee — the committee with direct jurisdiction over drug pricing provisions.” That analysis demonstrates research competency, not just data retrieval.
Describing Website Content Instead of Analyzing It
“AARP’s website says they support protecting Medicare and Social Security.” This tells your audience only that AARP has a website. It demonstrates no analytical engagement with the primary source. Your professor explicitly instructed you to review position statements and testimony — this response shows you read neither.
Instead
Engage with specific content: “AARP’s most recent position statement on Medicare drug pricing, published [month/year], explicitly endorses government negotiation authority under Medicare Part D and cites the Congressional Budget Office estimate that negotiation would save $X billion over ten years. This framing — using a nonpartisan budget authority’s own data — is AARP’s deliberate strategy to pre-empt fiscal objections by making the cost-saving argument before opponents can frame it as entitlement expansion.” That is primary source analysis.
Generic Obstacles Like “Partisan Gridlock”
“AHIP faces obstacles because Congress is divided and it is hard to pass health care legislation.” This is a background condition of American politics, not a group-specific obstacle. It applies equally to every interest group in the country and demonstrates no research into AHIP’s specific legislative environment.
Instead
Name the specific obstacle: “AHIP’s most significant current obstacle is growing bipartisan scrutiny of Medicare Advantage overpayment rates, documented in the MedPAC March 2023 report, which found MA plans are paid an average of 6% more than traditional Medicare for equivalent beneficiaries. This scrutiny comes from both progressive members who oppose private plan subsidies and fiscal conservatives focused on Medicare solvency — creating an unusual bipartisan coalition that AHIP cannot neutralize through standard partisan access strategies.” That is a researched, specific obstacle.
- OpenSecrets profile for your group is located; total lobbying expenditures for at least two years are recorded with year-over-year comparison
- At least three specific bills or issue areas from LD-2 filing records are identified — not just the total spending figure
- PAC contribution data is recorded including top five recipient legislators with their committee assignments
- Revolving-door lobbyist percentage is noted from the OpenSecrets “Lobbyists” tab
- The group’s official website policy or government affairs section has been reviewed; at least two specific position statements are cited by name and date
- At least one piece of congressional testimony from congress.gov is located, read, and cited with committee name, hearing date, and witness name
- At least one media report or external policy analysis is found through LexisNexis, Google News, or ProQuest that corroborates or complicates the group’s self-reported agenda
- Two or three specific, named obstacles are identified — not generic partisan gridlock, but structural or coalition-based barriers with evidence
- All OpenSecrets figures are cited as: Center for Responsive Politics. (year). [Organization name]. OpenSecrets. https://www.opensecrets.org/orgs/[org-id]
- The presentation’s analytical conclusion is a non-obvious claim supported by evidence from at least two of the three source types